Aishwarya Krishnan

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Dna Damage Response

Transforming Growth Factor

Top Venues

Molecular cancer research : MCR

This page only lists publications with an associated author ORCID identifier.

Publications

Andrew Dunbar, Dongjoo Kim, Min Lu, Mirko Farina, Robert L Bowman, Julie L Yang, Young C Park, Abdul Karzai, Wenbin Xiao, Zach Zaroogian, Kavi O'Connor, Shoron Mowla, Francesca Gobbo, Paola Verachi, Fabrizio Martelli, Giuseppe Sarli, Lijuan Xia, Nada Elmansy, Maria Kleppe, Zhuo Chen, Yang Xiao, Erin M McGovern, Jenna Snyder, Aishwarya Krishnan, Corinne E Hill, Keith Bryan Cordner, Anouar Zouak, Mohamed E Salama, Jayden Yohai, Eric Tucker, Jonathan J Chen, Jing Zhou, Timothy S McConnell, Anna Rita Migliaccio, Richard Patrick Koche, Raajit K Rampal, Rong Fan, Ross L Levine, Ronald Hoffman
CXCL8/CXCR2 signaling mediates bone marrow fibrosis and represents a therapeutic target in myelofibrosis. Blood (2023)
Bing Li, Wenbin An, Hua Wang, Timour Baslan, Shoron Mowla, Aishwarya Krishnan, Wenbin Xiao, Richard P Koche, Ying Liu, Sheng F Cai, Zhijian Xiao, Andriy Derkach, Ilaria Iacobucci, Charles G Mullighan, Kristian Helin, Scott W Lowe, Ross L Levine, Raajit K Rampal
BMP2/SMAD pathway activation in JAK2/p53-mutant megakaryocyte/erythroid progenitors promotes leukemic transformation. Blood 139 (25) (2022)
Aishwarya Krishnan, Aishwarya I Bhasker, Mithalesh Kumar Singh, Carlos Ivan Rodriguez, Edgardo Castro Pérez, Sarah Altameemi, Marcos Lares, Hamidullah Khan, Mary Ann Ndiaye, Nihal Ahmad, Stefan M Schieke, Vijayasaradhi Setaluri
EPAC Regulates Melanoma Growth by Stimulating mTORC1 Signaling and Loss of EPAC Signaling Dependence Correlates with Melanoma Progression. Molecular cancer research : MCR 20 (10) (2022)